Dr. Peter Bergqvist describes how some of his work contributed to a recent commercial outcome for TxCell (now Sangamo Therapeutics) with our academic partner Dr. Megan Levings at UBC.

The work has also been published here: https://insight.jci.org/articles/view/123672/sd/1